Preliminary Clinical Study of the Effects and Safety of 308-nm Excimer Light Treatment in Patients with Atopic Dermatitis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Atopic dermatitis (AD) is a common skin disease which, depending on its se- verity, can have a significant impact on the quality of life of affected individuals. In cases of severe AD, systemic immunomodulatory agents can be considered for treatment. However, the available treatment options for moderate AD are limited. According to previous reports, however, 308-nm excimer light is a potential treatment for localized, moderate AD. Objective: This study aimed to assess the clinical efficacy and safety of 308-nm excimer light in Korean adults with AD. Methods: This study included Korean patients aged over 19 years, who were diagnosed with AD by a dermatologist, with bilateral, symmetric, and eczematous lesions. The symmetrical lesions in each patient were treated as control-test pairs. Treatment with 308-nm excimer light was applied to the test lesion twice a week for 4 weeks. The severity of the eczema, trans-epidermal water loss, and epidermal capacitance were measured. Results: A total of 25 participants were enrolled in the study. After the first visit, two par- ticipants withdrew, whereas the remaining 23 completed the study. There was a statistically significant improvement in AD severity in the test group than in the control group (p<0.001). Skin barrier function also improved in the test than in the control group (p < 0 . 01). Conclusion: This study provides preliminary evidence for the use of 308-nm excimer light as a treatment option to improve symptoms and skin barrier function in moderately localized AD.
Abstract
Background: Atopic dermatitis (AD) is a common skin disease which, depending on its se- verity, can have a significant impact on the quality of life of affected individuals. In cases of severe AD, systemic immunomodulatory agents can be considered for treatment. However, the available treatment options for moderate AD are limited. According to previous reports, however, 308-nm excimer light is a potential treatment for localized, moderate AD. Objective: This study aimed to assess the clinical efficacy and safety of 308-nm excimer light in Korean adults with AD. Methods: This study included Korean patients aged over 19 years, who were diagnosed with AD by a dermatologist, with bilateral, symmetric, and eczematous lesions. The symmetrical lesions in each patient were treated as control-test pairs. Treatment with 308-nm excimer light was applied to the test lesion twice a week for 4 weeks. The severity of the eczema, trans-epidermal water loss, and epidermal capacitance were measured. Results: A total of 25 participants were enrolled in the study. After the first visit, two par- ticipants withdrew, whereas the remaining 23 completed the study. There was a statistically significant improvement in AD severity in the test group than in the control group (p<0.001). Skin barrier function also improved in the test than in the control group (p < 0 . 01). Conclusion: This study provides preliminary evidence for the use of 308-nm excimer light as a treatment option to improve symptoms and skin barrier function in moderately localized AD.
참고문헌 (16)
- 이지현, "Prevalence of Atopic Dermatitis in Korean Children Based on Data From the 2008-2011 Korean National Health and Nutrition Examination Survey", Allergy, Asthma & Immunology Research, 8(1), pp.79~83 (2016), 대한천식알레르기학회
- Thomas Bieber, "Atopic Dermatitis", Annals of Dermatology, 22(2), pp.125~137 (2010), 대한피부과학회
- 이지홍, "Therapeutic Efficacy and Safety of Methotrexate in Moderate-to-Severe Atopic Dermatitis: A Retrospective Study of Korean Patients at Tertiary Referral Hospital", Annals of Dermatology, 32(5), pp.402~408 (2020), 대한피부과학회
- 이지현, "Consensus Update for Systemic Treatment of Atopic Dermatitis", Annals of Dermatology, 33(6), pp.497~514 (2021), 대한피부과학회[DOI]
- Kemény L, "Advances in phototherapy for psoriasis and atopic dermatitis", Expert Rev Clin Immunol, 15, pp.1205~1214 (2019)
- Aubin F, "Evaluation of a novel 308-nm monochromatic excimer light delivery system in dermatology : a pilot study in different chronic localized dermatoses", Br J Dermatol, 152, pp.99~103 (2005)
- Baltás E, "Treatment of atopic dermatitis with the xenon chloride excimer laser", J Eur Acad Dermatol Venereol, 20, pp.657~660 (2006)
- Kurosaki Y, "Effects of 308 nm excimer light treatment on the skin microbiome of atopic dermatitis patients", Photodermatol Photoimmunol Photomed, 36, pp.185~191 (2020)
- Nisticò SP, "Efficacy of monochromatic excimer light(308 nm)in the treatment of atopic dermatitis in adults and children", Photomed Laser Surg, 26, pp.14~18 (2008)
- Oh CT, "Effect of a 308-nm excimer laser on atopic dermatitis-like skin lesions in NC", Nga mice, 2016, pp.48, 629~637
- Hanifin JM, "Diagnostic features of atopic dermatitis", Acta Derm Venereol Suppl(Stockh), 92, pp.44~47 (1980)
- 안지영, "Therapeutic New Era for Atopic Dermatitis: Part 2. Small Molecules", Annals of Dermatology, 33(2), pp.101~107 (2021), 대한피부과학회[DOI]
- Bónis B, "308 nm UVB excimer laser for psoriasis", Lancet, 350, pp.1522~ (1997)
- Novák Z, "Xenon chloride ultraviolet B laser is more effective in treating psoriasis and in inducing T cell apoptosis than narrow-band ultraviolet B", J Photochem Photobiol B, 67, pp.32~38 (2002)
- Wolkerstorfer A, "Excimer laser : a treatment option for the prurigo form of atopic dermatitis", Expert Rev Dermatol, 6, pp.1~3 (2011)
- Park JY, "Efficacy of phototherapy with 308-nm excimer light for skin microbiome dysbiosis and skin barrier dysfunction in canine atopic dermatitis", Front Vet Sci, 8, pp.762961~ (2021)